您要查找的是不是：
- invasive ductal carcionma 浸润性导管癌
- The pathologic result was intermediate-nuclear-grade invasive ductal carcinoma. 病理结果为核中等分化的导管癌。
- Case 2A 58-year-old woman with invasive ductal carcinoma of the left breast performed mastectomy. 病例2女，58岁，左乳浸润性导管癌，左乳全切。
- Objective To study the expression of proapoptosis gene bak in Invasive ductal carcinoma(IDC) in the pathogenesis of IDC. 目的研究细胞凋亡相关基因bak在乳腺浸润性导管癌(invasive ductal carcinoma;IDC)组织中的表达,探讨bak基因在IDC发生演变过程中的意义。
- Objective To study the relationship of the expression of Fas and Fas L with the pathogenesis and differentiation of breast invasive ductal carcinomas. 目的 探讨Fas 及Fas?L与乳腺浸润性导管癌发生、发展及肿瘤分化程度的关系。
- The expression level of AMF or AMFR in invasive ductal carcinomas was higher than that in ductal carcinomas in situ( P <0.05). 浸润性导管癌AMF、AMFR水平明显高于导管内癌 (P =0 .;0 0 1)。
- It also differs from other forms of invasive ductal cancers in that it contains large cancer cells and immune system cells at the edges of the tumor. 肿瘤表面为免疫系统细胞，而里面为大量的癌细胞，这一点和其他的浸润性导管癌也不相同。
- The expression of P63 in breast invasive ductal carcinoma was weak and 8 cases (8.3%) showed rare neoplatic cells positive staining. P63在乳腺浸润性导管癌中有8例(8.;3%25)呈现少量的肿瘤细胞阳性，并且主要表达于低分化的乳腺癌中。
- The large cells infiltrating into the epidermis represent intraepithelial extension of an underlying ductal carcinoma in situ or invasive ductal carcinoma. 浸润至真皮的大细胞说明位于下方的导管原位癌或浸润性导管癌向上皮内侵犯。
- Objective To study the relationship between the expression of p57KIP2 and clinicopathological characteristics in invasive duct carcinoma(IDC). 目的研究p57KIP2在乳腺浸润性导管癌(invasive duct carcinoma,IDC)中的表达及与临床病理特征的关系。
- Purpose To study the relation of the perineural Invaslon in breast invasive ductal carcinoma tothe size, histological classification, TNM period, metastases of lymph nodes and 5 years survival rate of the tu-mor. 目的：对乳腺浸润性导管癌神经周浸润与肿瘤的大小、肿瘤的组织学分级、肿瘤的TNM分期、淋巴结转移、5年存活率、肿瘤标志物CEA等之间的关系进行探讨。
- However, the positive rates of GCDFP-15 expression in bot h the du ctal carcinoma in situ (81%) and the surrounding normal lobules (71.6%) were si gni ficantly higher than that in invasive ductal carcinoma (P<0.01 and P<0 .001). 导管原位癌表达率 81%25 ;明显高于浸润性癌 (P <0 0 1)。 周围正常乳腺小叶表达率为 71 6%25 ;明显高于浸润性癌 (P <0 0 1)。
- Methods Both carcinoma tissues and their surrounding tissues from 50 patients with breast invasive ductal carcinomas were studied for the expression of Fas and Fas L by immunohistochemical staining. 方法 用免疫组织化学方法对50 例乳腺浸润性导管癌及其癌旁组织的Fas 及Fas?L进行检测。
- In invasive ductal and lobular carcinoma the strums was devoid of CD34 (superscript +) fibrocytes, but a varying number of stromal SMA-reactive myofibroblasts were detectable (100%). 浸润性导管癌和小叶癌的浸润的病灶内未见CD34(上标+)细胞，可见SMA阳性表达的肌纤维母细胞(100%25)。
- primary breast invasive ductal carcinoma 原发性乳腺浸润性导管癌
- invasive ductal cancer with breast infiltrations 乳腺浸润性导管癌
- Invasive ductal carcinoma of breast 乳腺浸润性导管癌
- Invasive ductal carcinoma of the breast 乳腺浸润性导管癌
- Breast invasive ductal carcinoma 乳腺浸润性导管癌
- Human primary breast invasive ductal carcinoma 原发性乳腺浸润性导管癌
